
Akm E. Ullah
Examiner (ID: 10221, Phone: (571)272-2361 , Office: P/2874 )
| Most Active Art Unit | 2874 |
| Art Unit(s) | 2874, 2606, 2501, 1734, 2899, 3621, 2838 |
| Total Applications | 3400 |
| Issued Applications | 3065 |
| Pending Applications | 95 |
| Abandoned Applications | 245 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6486393
[patent_doc_number] => 20020152493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'Transgenic mice containing PTP36 tyrosine phosphatase gene disruptions'
[patent_app_type] => new
[patent_app_number] => 10/005467
[patent_app_country] => US
[patent_app_date] => 2001-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20413
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20020152493.pdf
[firstpage_image] =>[orig_patent_app_number] => 10005467
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/005467 | Transgenic mice containing PTP36 tyrosine phosphatase gene disruptions | Dec 3, 2001 | Abandoned |
Array
(
[id] => 6557975
[patent_doc_number] => 20020194636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Transgenic mice containing polycystin-related gene disruptions'
[patent_app_type] => new
[patent_app_number] => 10/005211
[patent_app_country] => US
[patent_app_date] => 2001-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 20316
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20020194636.pdf
[firstpage_image] =>[orig_patent_app_number] => 10005211
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/005211 | Transgenic mice containing polycystin-related gene disruptions | Dec 3, 2001 | Abandoned |
Array
(
[id] => 5927039
[patent_doc_number] => 20020116729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Transgenic mice containing NTTP1 phosphatase gene disruptions'
[patent_app_type] => new
[patent_app_number] => 10/005858
[patent_app_country] => US
[patent_app_date] => 2001-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19831
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20020116729.pdf
[firstpage_image] =>[orig_patent_app_number] => 10005858
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/005858 | Transgenic mice containing NTTP1 phosphatase gene disruptions | Dec 3, 2001 | Abandoned |
Array
(
[id] => 5985160
[patent_doc_number] => 20020098223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'Biocompatible implant for the expression and in vivo secretion of a therapeutic substance'
[patent_app_type] => new
[patent_app_number] => 09/987601
[patent_app_country] => US
[patent_app_date] => 2001-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11718
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 37
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20020098223.pdf
[firstpage_image] =>[orig_patent_app_number] => 09987601
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/987601 | Biocompatible implant for the expression and in vivo secretion of a therapeutic substance | Nov 14, 2001 | Abandoned |
Array
(
[id] => 6861092
[patent_doc_number] => 20030092100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Tn7 transposition method for producing mutant genes'
[patent_app_type] => new
[patent_app_number] => 10/010288
[patent_app_country] => US
[patent_app_date] => 2001-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8977
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092100.pdf
[firstpage_image] =>[orig_patent_app_number] => 10010288
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/010288 | Tn7 transposition method for producing mutant genes | Nov 12, 2001 | Abandoned |
| 10/009445 | Ox2 receptor homologs | Nov 12, 2001 | Abandoned |
Array
(
[id] => 5927040
[patent_doc_number] => 20020116730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Transgenic mice containing PERK protein kinase gene disruptions'
[patent_app_type] => new
[patent_app_number] => 10/005983
[patent_app_country] => US
[patent_app_date] => 2001-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20009
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20020116730.pdf
[firstpage_image] =>[orig_patent_app_number] => 10005983
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/005983 | Transgenic mice containing PERK protein kinase gene disruptions | Nov 6, 2001 | Abandoned |
Array
(
[id] => 6683323
[patent_doc_number] => 20030119187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Antigen presenting cells, method for their preparation and their use for cancer vaccines'
[patent_app_type] => new
[patent_app_number] => 09/981239
[patent_app_country] => US
[patent_app_date] => 2001-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10033
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119187.pdf
[firstpage_image] =>[orig_patent_app_number] => 09981239
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/981239 | Antigen presenting cells, method for their preparation and their use for cancer vaccines | Oct 17, 2001 | Abandoned |
Array
(
[id] => 6086143
[patent_doc_number] => 20020083481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Vectors and methods for the mutagenesis of mammalian genes'
[patent_app_type] => new
[patent_app_number] => 09/982586
[patent_app_country] => US
[patent_app_date] => 2001-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8867
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20020083481.pdf
[firstpage_image] =>[orig_patent_app_number] => 09982586
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/982586 | Vectors and methods for the mutagenesis of mammalian genes | Oct 16, 2001 | Abandoned |
Array
(
[id] => 5828214
[patent_doc_number] => 20020068274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-06
[patent_title] => 'Novel method for assessing recoding in vitro and in vivo'
[patent_app_type] => new
[patent_app_number] => 09/981393
[patent_app_country] => US
[patent_app_date] => 2001-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11755
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20020068274.pdf
[firstpage_image] =>[orig_patent_app_number] => 09981393
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/981393 | Novel method for assessing recoding in vitro and in vivo | Oct 15, 2001 | Abandoned |
Array
(
[id] => 1053441
[patent_doc_number] => 06858772
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-02-22
[patent_title] => 'Transgenic mice containing magnesium-dependent protein phosphatase gene disruptions'
[patent_app_type] => utility
[patent_app_number] => 09/972741
[patent_app_country] => US
[patent_app_date] => 2001-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 20390
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/858/06858772.pdf
[firstpage_image] =>[orig_patent_app_number] => 09972741
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/972741 | Transgenic mice containing magnesium-dependent protein phosphatase gene disruptions | Oct 4, 2001 | Issued |
Array
(
[id] => 1275807
[patent_doc_number] => 06637366
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-28
[patent_title] => 'Nematode biopesticide'
[patent_app_type] => B1
[patent_app_number] => 09/869080
[patent_app_country] => US
[patent_app_date] => 2001-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4058
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/637/06637366.pdf
[firstpage_image] =>[orig_patent_app_number] => 09869080
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/869080 | Nematode biopesticide | Sep 30, 2001 | Issued |
| 09/868310 | In vivo odontogenic model using rodent's mandibular incisor | Sep 30, 2001 | Abandoned |
Array
(
[id] => 5971866
[patent_doc_number] => 20020092034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-11
[patent_title] => 'Non-human model of gestational and adult folate deficiency and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/962290
[patent_app_country] => US
[patent_app_date] => 2001-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14923
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20020092034.pdf
[firstpage_image] =>[orig_patent_app_number] => 09962290
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/962290 | Non-human model of gestational and adult folate deficiency and uses thereof | Sep 23, 2001 | Abandoned |
Array
(
[id] => 6175586
[patent_doc_number] => 20020155421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => 'Endothelial cell mitogen bioassay'
[patent_app_type] => new
[patent_app_number] => 09/961128
[patent_app_country] => US
[patent_app_date] => 2001-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4228
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20020155421.pdf
[firstpage_image] =>[orig_patent_app_number] => 09961128
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/961128 | Endothelial cell mitogen bioassay | Sep 20, 2001 | Abandoned |
Array
(
[id] => 6861175
[patent_doc_number] => 20030092183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Rapid creation of gene targeting vectors using homologous recombination in yeast'
[patent_app_type] => new
[patent_app_number] => 09/961163
[patent_app_country] => US
[patent_app_date] => 2001-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11391
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092183.pdf
[firstpage_image] =>[orig_patent_app_number] => 09961163
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/961163 | Rapid creation of gene targeting vectors using homologous recombination in yeast | Sep 20, 2001 | Abandoned |
Array
(
[id] => 6711089
[patent_doc_number] => 20030170838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Novel polynucleotides and polypeptides encoded thereby'
[patent_app_type] => new
[patent_app_number] => 09/954342
[patent_app_country] => US
[patent_app_date] => 2001-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70761
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170838.pdf
[firstpage_image] =>[orig_patent_app_number] => 09954342
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/954342 | Novel polynucleotides and polypeptides encoded thereby | Sep 16, 2001 | Abandoned |
Array
(
[id] => 1068630
[patent_doc_number] => 06844156
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-18
[patent_title] => 'Methods for identifying a preferred liver transplant donor'
[patent_app_type] => utility
[patent_app_number] => 09/955407
[patent_app_country] => US
[patent_app_date] => 2001-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 7938
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/844/06844156.pdf
[firstpage_image] =>[orig_patent_app_number] => 09955407
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/955407 | Methods for identifying a preferred liver transplant donor | Sep 11, 2001 | Issued |
Array
(
[id] => 1181358
[patent_doc_number] => 06740793
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-05-25
[patent_title] => 'Transgenic animal having a disrupted PDE7A gene and uses thereof'
[patent_app_type] => B2
[patent_app_number] => 09/950920
[patent_app_country] => US
[patent_app_date] => 2001-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11972
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/740/06740793.pdf
[firstpage_image] =>[orig_patent_app_number] => 09950920
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/950920 | Transgenic animal having a disrupted PDE7A gene and uses thereof | Sep 11, 2001 | Issued |
Array
(
[id] => 1171059
[patent_doc_number] => 06753456
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-06-22
[patent_title] => 'Point mutant mice with hypersensitive alpha 4 nicotinic receptors: dopaminergic pathology and increased anxiety'
[patent_app_type] => B2
[patent_app_number] => 09/949298
[patent_app_country] => US
[patent_app_date] => 2001-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 20
[patent_no_of_words] => 12560
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/753/06753456.pdf
[firstpage_image] =>[orig_patent_app_number] => 09949298
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/949298 | Point mutant mice with hypersensitive alpha 4 nicotinic receptors: dopaminergic pathology and increased anxiety | Sep 6, 2001 | Issued |